(You are encouraged to copy and distribute this notification.)
Update: July 16, 2007
Original publication date: February 27, 2007
Dear Colleague:
This is to update you on new information regarding the Custom Ultrasonics endoscope washer/disinfector, and to provide recommendations for facilities either using these products or planning to use those that have been taken out of service.
On January 25, 2007, FDA entered into a Consent Decree to Custom Ultrasonics, Inc., because the firm failed to comply with FDA regulations that help ensure that medical devices are safe and effective. As part of the Decree, the company agreed to stop manufacturing and distributing all devices it manufactures, including the System 83 Plus Washer/Disinfector, the System 83 Plus MiniFlex Washer/Disinfector, and all accessories. http://www.fda.gov/cdrh/safety/022707-ultrasonics-archived.html
On May 8, 2007, the FDA issued a letter to Custom Ultrasonics stating that the firm has now complied with the requirements of the Consent Decree and is permitted to resume manufacturing the System 83 Plus Washer/Disinfector and all accessories. FDA's most recent inspection of the firm completed on March 29, 2007, found its manufacturing operation to be in compliance with FDA's Quality System regulation. The firm has also been found to be in substantial compliance with the Medical Device Reporting (MDR) regulation.
For facilities that suspended use of their Custom Ultrasonics endoscope washer/disinfectors:
For facilities that continued using their Custom Ultrasonics endoscope washer/disinfectors:
For all users:
FDA requires hospitals and other user facilities to report deaths and serious injuries associated with the use of medical devices. If you suspect that a reportable adverse event was related to the use of a Custom Ultrasonics endoscope washer/disinfector, you should follow the reporting procedure established by your facility.
We also encourage you to report adverse events related to Custom Ultrasonics endoscope washer/disinfectors that do not meet the requirements for mandatory reporting. You can report these directly to the device manufacturer or to MedWatch, the FDA’s voluntary adverse event reporting program. This can be done online at www.fda.gov/medwatch/report.htm , by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, or by mailing FDA form 3500 (download from www.fda.gov/MedWatch/getforms.htm) to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787 or faxing to 1-800-FDA-0178.
Custom Ultrasonics can be contacted at 215-364-1477.
If you have questions about this FDA Notification, please contact the Office of Surveillance and Biometrics (HFZ-510), 1350 Piccard Drive, Rockville, Maryland, 20850, Fax at 240-276-3356, or by e-mail at phann@cdrh.fda.gov. You may also leave a voice mail message at 240-276-3357 and we will return your call as soon as possible.
FDA medical device Public Health Notifications are available on the Internet at http://www.fda.gov/cdrh/safety.html. You can also be notified through e-mail each time a new Public Health Notification is added to our web page. To subscribe to this service, visit: http://service.govdelivery.com/service/subscribe.html?code=USFDACDRH_10.
Sincerely yours,
Daniel G. Schultz, MD
Director
Center for Devices and Radiological Health
Food and Drug Administration
Updated July 19, 2007
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH